Immediate Impact
2 from Science/Nature 54 standout
Citing Papers
Endocrine Controls of Skin Aging
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Fumio Nambu being referenced
In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist.
1992
In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist
1992
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fumio Nambu | 151 | 78 | 74 | 97 | 20 | 344 | |
| G. Brunet | 181 | 102 | 59 | 89 | 16 | 375 | |
| A. Bertolino | 89 | 26 | 70 | 128 | 28 | 382 | |
| Shinji Murata | 54 | 30 | 35 | 71 | 36 | 379 | |
| Xinran Niu | 163 | 18 | 9 | 61 | 16 | 355 | |
| Kevin Liu | 136 | 37 | 19 | 164 | 13 | 365 | |
| Yin Yeng Lee | 129 | 16 | 32 | 81 | 11 | 324 | |
| Marie-Ève Rivard | 76 | 9 | 34 | 136 | 17 | 404 | |
| Theresa Brand | 38 | 26 | 25 | 119 | 17 | 372 | |
| Viola Mechírová | 51 | 11 | 29 | 138 | 12 | 393 | |
| Sandy Wilson | 29 | 7 | 98 | 166 | 18 | 384 |
All Works
Loading papers...